IT1224673B - Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella - Google Patents

Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella

Info

Publication number
IT1224673B
IT1224673B IT8848173A IT4817388A IT1224673B IT 1224673 B IT1224673 B IT 1224673B IT 8848173 A IT8848173 A IT 8848173A IT 4817388 A IT4817388 A IT 4817388A IT 1224673 B IT1224673 B IT 1224673B
Authority
IT
Italy
Prior art keywords
esuo
somatostatin
analog
treatment
pharmaceutical composition
Prior art date
Application number
IT8848173A
Other languages
English (en)
Other versions
IT8848173A0 (it
Inventor
Cavanak Thomas
Harris Alan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8848173A0 publication Critical patent/IT8848173A0/it
Application granted granted Critical
Publication of IT1224673B publication Critical patent/IT1224673B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8848173A 1987-07-10 1988-07-11 Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella IT1224673B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (2)

Publication Number Publication Date
IT8848173A0 IT8848173A0 (it) 1988-07-11
IT1224673B true IT1224673B (it) 1990-10-18

Family

ID=10620471

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848173A IT1224673B (it) 1987-07-10 1988-07-11 Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella

Country Status (6)

Country Link
KR (1) KR100195894B1 (it)
AT (1) AT402896B (it)
GB (1) GB8716324D0 (it)
HU (1) HU206271B (it)
IT (1) IT1224673B (it)
ZA (1) ZA884941B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3215597A (en) 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
US20180325993A1 (en) * 2017-05-15 2018-11-15 Sun Pharmaceutical Industries Limited Octreotide injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions

Also Published As

Publication number Publication date
AT402896B (de) 1997-09-25
HU206271B (en) 1992-10-28
GB8716324D0 (en) 1987-08-19
ATA177788A (de) 1997-02-15
KR100195894B1 (ko) 1999-06-15
ZA884941B (en) 1990-03-28
HU906980D0 (en) 1991-05-28
IT8848173A0 (it) 1988-07-11
KR890001583A (ko) 1989-03-27

Similar Documents

Publication Publication Date Title
IT8767624A0 (it) Dispositivo per il massaggio manuale del rivestimento cutaneo
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
DK8987A (da) Lysstraaleklaede for medicinsk behandling
IT1193395B (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che li contengono
IT8648358A0 (it) Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT1224594B (it) Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene
DK360188D0 (da) Laegemiddelafgivelsesorgan
GB2243296B (en) Treatment of disease associated with hiv-infections
IT1153294B (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle
IT8720181A0 (it) Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata.
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
IT1224673B (it) Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
DK143488A (da) Laegemiddel til behandling af cancer
GB2239178B (en) Somatostatin analogues for the treatment of breast cancer
JPS53148893A (en) Inspirator for medical treatment
DK38986D0 (da) Medicinsk inhalationsapparat
IT8748518A0 (it) Terapia combinata di interferone con antiestrogeno per il trattamento del cancro della mammella
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
IT1148019B (it) Procedimento per la produzione del l'ormone umano stimolatore della tiroide
KR890008386U (ko) 한약 농축기
IT8648164A0 (it) Composizione farmaceutica per il trattamento della cellulite

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970623